Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237170 · ClinicalTrials.gov registry record
Immune Monitoring on Sipuleucel-T
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 36
- Enrollment target
NCT02237170 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 36 participants.
The verdict
NCT02237170 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this protocol is perform comprehensive immune monitoring studies in patients with castration-resistant prostate cancer receiving Sipuleucel-T in an effort to better understand the mechanism of action of this treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02237170
The ClinicalTrials.gov registry entry for NCT02237170 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02237170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02237170 about?
NCT02237170 is a clinical study titled "Immune Monitoring on Sipuleucel-T". The purpose of this protocol is perform comprehensive immune monitoring studies in patients with castration-resistant prostate cancer receiving Sipuleucel-T in an effort to better understand the mechanism of action of this treatment.
What is the current status of trial NCT02237170?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2012-06. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02237170?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.